These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25777762)

  • 1. Mouse models of autoimmune diseases: immune thrombocytopenia.
    Neschadim A; Branch DR
    Curr Pharm Des; 2015; 21(18):2487-97. PubMed ID: 25777762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse Models for Immune-Mediated Platelet Destruction or Immune Thrombocytopenia (ITP).
    Neschadim A; Branch DR
    Curr Protoc Immunol; 2016 Apr; 113():15.30.1-15.30.13. PubMed ID: 27038460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on the pathophysiology of immune thrombocytopenia.
    Semple JW; Rebetz J; Maouia A; Kapur R
    Curr Opin Hematol; 2020 Nov; 27(6):423-429. PubMed ID: 32868673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet destruction in immune thrombocytopenia. Understanding the mechanisms.
    Bakchoul T; Sachs UJ
    Hamostaseologie; 2016 Aug; 36(3):187-94. PubMed ID: 25982994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of immune thrombocytopenia.
    Li J; Sullivan JA; Ni H
    Curr Opin Hematol; 2018 Sep; 25(5):373-381. PubMed ID: 30015642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Fcgamma receptors in murine autoimmune thrombocytopenia.
    Biburger M; Aschermann S; Lux A; Nimmerjahn F
    Ann Hematol; 2010 Jul; 89 Suppl 1():25-30. PubMed ID: 20179927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet antibody-induced thrombocytopenia does not correlate with megakaryocyte abnormalities in murine immune thrombocytopenia.
    Guo L; Kapur R; Aslam R; Hunt K; Hou Y; Zufferey A; Speck ER; Rondina MT; Lazarus AH; Ni H; Semple JW
    Scand J Immunol; 2018 Jul; 88(1):e12678. PubMed ID: 29855061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent progress of study on mechanism of immune thrombocytopenic purpura and its clinical treatment - review].
    Lu XC; Zhu HL; Yao SQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1232-6. PubMed ID: 18928635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production.
    McMillan R
    Hematol Oncol Clin North Am; 2009 Dec; 23(6):1163-75. PubMed ID: 19932426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular immune dysregulation in the pathogenesis of immune thrombocytopenia.
    Wen R; Wang Y; Hong Y; Yang Z
    Blood Coagul Fibrinolysis; 2020 Mar; 31(2):113-120. PubMed ID: 31977328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes.
    Meabed MH; Taha GM; Mohamed SO; El-Hadidy KS
    Hematology; 2007 Aug; 12(4):301-7. PubMed ID: 17654056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine profiles in mouse models of experimental immune thrombocytopenia reveal a lack of inflammation and differences in response to intravenous immunoglobulin depending on the mouse strain.
    Leontyev D; Neschadim A; Branch DR
    Transfusion; 2014 Nov; 54(11):2871-9. PubMed ID: 24826802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal antibody with anti-D-like activity in murine immune thrombocytopenia requires Fc domain function for immune thrombocytopenia ameliorative effects.
    Yu X; Menard M; Seabright G; Crispin M; Lazarus AH
    Transfusion; 2015 Jun; 55(6 Pt 2):1501-11. PubMed ID: 25752470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current treatment of primary immune thrombocytopenia].
    Lozano ML; Vicente V
    Med Clin (Barc); 2014 May; 142(9):399-405. PubMed ID: 23809409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current therapies in primary immune thrombocytopenia.
    Pels SG
    Semin Thromb Hemost; 2011 Sep; 37(6):621-30. PubMed ID: 22102265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption.
    Crow AR; Amash A; Lazarus AH
    Transfusion; 2015 Jun; 55(6 Pt 2):1492-500. PubMed ID: 25496771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic idiopathic thrombocytopenic purpura: mechanisms of pathogenesis.
    Gernsheimer T
    Oncologist; 2009 Jan; 14(1):12-21. PubMed ID: 19144680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy.
    Chow L; Aslam R; Speck ER; Kim M; Cridland N; Webster ML; Chen P; Sahib K; Ni H; Lazarus AH; Garvey MB; Freedman J; Semple JW
    Blood; 2010 Feb; 115(6):1247-53. PubMed ID: 20007808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Idiopathic thrombocytopenic purpura in children].
    Gebauer E; Vijatov G
    Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic approaches to secondary immune thrombocytopenic purpura.
    Bussel JB
    Semin Hematol; 2009 Jan; 46(1 Suppl 2):S44-58. PubMed ID: 19245934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.